{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:50:38Z","timestamp":1792792238931,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T00:00:00Z","timestamp":1462924800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"NIH\/NCI Cancer Center Support Grant","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1245\/s10434-016-5259-3","type":"journal-article","created":{"date-parts":[[2016,5,11]],"date-time":"2016-05-11T18:57:33Z","timestamp":1462993053000},"page":"3481-3486","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Age and Receptor Status Do Not Indicate the Need for Axillary Dissection in Patients with Sentinel Lymph Node Metastases"],"prefix":"10.1245","volume":"23","author":[{"given":"Anita","family":"Mamtani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujata","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9550-4647","authenticated-orcid":false,"given":"Kimberly J.","family":"Van Zee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Hiram S.","family":"Cody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Pilewskie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea V.","family":"Barrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra S.","family":"Heerdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,11]]},"reference":[{"key":"5259_CR1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/jnci\/djj158","volume":"98","author":"RE Mansel","year":"2006","unstructured":"Mansel RE, Fallowfield L, Kissin M, Goyal A, Newcombe RG, Dixon JM, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst. 2006;98:599\u2013609.","journal-title":"J Natl Cancer Inst."},{"key":"5259_CR2","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","volume":"11","author":"DN Krag","year":"2010","unstructured":"Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Costantino JP, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol. 2010;11:927\u201333.","journal-title":"Lancet Oncol."},{"issue":"11","key":"5259_CR3","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.ejca.2004.04.006","volume":"40","author":"A Goyal","year":"2004","unstructured":"Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE. Predictors of non-sentinel lymph node metastasis in breast cancer patients. Eur J Cancer. 2004;40(11):1731\u20137.","journal-title":"Eur J Cancer."},{"key":"5259_CR4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/SLA.0b013e3181f08f32","volume":"252","author":"AE Giuliano","year":"2010","unstructured":"Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American college of surgeons oncology group z0011 randomized trial. Ann Surg. 2010;252:426\u201332.","journal-title":"Ann Surg."},{"key":"5259_CR5","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, Meijnen P, van de Velde CJH, Mansel RE, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 noninferiority trial. Lancet Oncol. 2014;15:1303\u201310.","journal-title":"Lancet Oncol."},{"key":"5259_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1245\/s10434-013-3200-6","volume":"21","author":"LT Dengel","year":"2014","unstructured":"Dengel LT, Van Zee KJ, King TA, Stempel M, Cody HS, El-Tamer M, et al. Axillary dissection can be avoided in the majority of clinically node-negative patients undergoing breast-conserving therapy. Ann Surg Oncol. 2014;21:22\u20137.","journal-title":"Ann Surg Oncol."},{"key":"5259_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jamcollsurg.2015.02.035","volume":"221","author":"K Yao","year":"2015","unstructured":"Yao K, Liederbach E, Pesce C, Wang CH, Winchester DJ. Impact of the American College of Surgeons Oncology Group Z0011 randomized trial on the number of axillary nodes removed for patients with early-stage breast cancer. J Am Coll Surg. 2015;221:71\u201381.","journal-title":"J Am Coll Surg."},{"key":"5259_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1245\/s10434-008-0229-z","volume":"16","author":"G Gill","year":"2009","unstructured":"Gill G. Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol. 2009;16:266\u201375.","journal-title":"Ann Surg Oncol."},{"key":"5259_CR9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/jnci\/91.4.368","volume":"91","author":"U Veronesi","year":"1999","unstructured":"Veronesi U, Paganelli G, Viale G, Galimberti V, Luini A, Zurrida S, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst. 1999;91:368\u201373.","journal-title":"J Natl Cancer Inst."},{"key":"5259_CR10","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1245\/ASO.2003.03.015","volume":"10","author":"KJ Zee Van","year":"2003","unstructured":"Van Zee KJ, Manasseh DM, Bevilacqua JL, Boolbol SK, Fey JV, Tan LK, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol. 2003;10:1140\u201351.","journal-title":"Ann Surg Oncol."},{"key":"5259_CR11","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1245\/s10434-014-4090-y","volume":"22","author":"A Chung","year":"2015","unstructured":"Chung A, Gangi A, Mirocha J, Giuliano A. Applicability of the ACOSOG Z0011 criteria in women with high-risk node-positive breast cancer undergoing breast conserving surgery. Ann Surg Oncol. 2015;22:1128\u201332.","journal-title":"Ann Surg Oncol."},{"key":"5259_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3816\/CBC.2008.n.028","volume":"8","author":"SJ Crabb","year":"2008","unstructured":"Crabb SJ, Cheang MC, Leung S, Immonen T, Nielsen TO, Huntsman DD, et al. Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer. Clin Breast Cancer. 2008;8:249\u201356.","journal-title":"Clin Breast Cancer."},{"key":"5259_CR13","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1245\/s10434-014-3851-y","volume":"21","author":"S Ugras","year":"2014","unstructured":"Ugras S, Stempel M, Patil S, Morrow M. Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement. Ann Surg Oncol. 2014;21:3780\u20136.","journal-title":"Ann Surg Oncol."},{"key":"5259_CR14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10549-015-3341-3","volume":"150","author":"K Kast","year":"2015","unstructured":"Kast K, Link T, Friedrich K, Petzold A, Niedostatek A, Schoffer O, et al. Impact of breast cancer subtypes and patterns of metastasis on outcome. Breast Cancer Res Treat. 2015;150:621\u20139.","journal-title":"Breast Cancer Res Treat."},{"key":"5259_CR15","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s10549-011-1891-6","volume":"133","author":"AJ Lowery","year":"2012","unstructured":"Lowery AJ, Kell MR, Glynn RW, Kerin MJ, Sweeney KJ. Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Res Treat. 2012;133:831\u201341.","journal-title":"Breast Cancer Res Treat."},{"key":"5259_CR16","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1245\/s10434-009-0606-2","volume":"16","author":"L Wiechmann","year":"2009","unstructured":"Wiechmann L, Sampson M, Stempel M, Jacks LM, Patil SM, King T, et al. Presenting features of breast cancer differ by molecular subtype. Ann Surg Oncol. 2009;16:2705\u201310.","journal-title":"Ann Surg Oncol."},{"key":"5259_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/tbj.12276","volume":"20","author":"GM Freedman","year":"2014","unstructured":"Freedman GM, Fowble BL, Li T, Hwang ES, Schechter N, Devarajan K, et al. Risk of positive nonsentinel nodes in women with 1\u20132 positive sentinel nodes related to age and molecular subtype approximated by receptor status. Breast J. 2014;20:358\u201363.","journal-title":"Breast J."},{"key":"5259_CR18","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.1245\/s10434-014-3989-7","volume":"21","author":"A Gangi","year":"2014","unstructured":"Gangi A, Mirocha J, Leong T, Giuliano AE. Triple-negative breast cancer is not associated with increased likelihood of nodal metastases. Ann Surg Oncol. 2014;21:4098\u2013103.","journal-title":"Ann Surg Oncol."},{"key":"5259_CR19","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1200\/JCO.2005.07.032","volume":"23","author":"AU Buzdar","year":"2005","unstructured":"Buzdar AU, Ibrahim NK, Francis D, Booser DJ, Thomas ES, Theriault RL, et al. Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer. J Clin Oncol. 2005;23:3676\u201385.","journal-title":"J Clin Oncol."},{"key":"5259_CR20","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/S1470-2045(14)70080-4","volume":"15","author":"L Gianni","year":"2014","unstructured":"Gianni L, Eiermann W, Semiglazov V, Lluch A, Tjulandin S, Zambetti M, et al. Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort. Lancet Oncol. 2014;15:640\u20137.","journal-title":"Lancet Oncol."},{"key":"5259_CR21","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1200\/JCO.2006.09.9994","volume":"25","author":"BP Coudert","year":"2007","unstructured":"Coudert BP, Largillier R, Arnould L, Chollet P, Campone M, Coeffic D, et al. Multicenter phase II trial of neoadjuvant therapy with trastuzumab, docetaxel, and carboplatin for human epidermal growth factor receptor-2-overexpressing stage II or III breast cancer: results of the GETN(A)-1 trial. J Clin Oncol. 2007;25:2678\u201384.","journal-title":"J Clin Oncol."},{"key":"5259_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13058-015-0568-1","volume":"17","author":"K Strasser-Weippl","year":"2015","unstructured":"Strasser-Weippl K, Horick N, Smith IE, O\u2019Shaughnessy J, Ejlertsen B, Boyle F, et al. Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy. Breast Cancer Res. 2015;17:56.","journal-title":"Breast Cancer Res."},{"key":"5259_CR23","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1200\/JCO.1996.14.10.2738","volume":"14","author":"T Saphner","year":"1996","unstructured":"Saphner T, Tormey DC, Gray R. Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol. 1996;14:2738\u201346.","journal-title":"J Clin Oncol."},{"key":"5259_CR24","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1200\/JCO.2011.36.1105","volume":"29","author":"ND Arvold","year":"2011","unstructured":"Arvold ND, Taghian AG, Niemierko A, Abi Raad RF, Sreedhara M, Nguyen PL, et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol. 2011;29:3885\u201391.","journal-title":"J Clin Oncol."},{"key":"5259_CR25","doi-asserted-by":"publisher","first-page":"5700","DOI":"10.1200\/JCO.2009.23.2025","volume":"27","author":"AM Gonzalez-Angulo","year":"2009","unstructured":"Gonzalez-Angulo AM, Litton JK, Broglio KR, Meric-Bernstam F, Rakkhit R, Cardoso F, et al. High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller. J Clin Oncol. 2009;27:5700\u20136.","journal-title":"J Clin Oncol."},{"key":"5259_CR26","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1016\/j.ijrobp.2011.02.061","volume":"82","author":"JA Hattangadi-Gluth","year":"2012","unstructured":"Hattangadi-Gluth JA, Wo JY, Nguyen PL, Abi Raad RF, Sreedhara M, Niemierko A, et al. Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2012;82:1185\u201391","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"5259_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.suronc.2013.10.001","volume":"22","author":"J Wang","year":"2013","unstructured":"Wang J, Xie X, Wang X, Tang J, Pan Q, Zhang Y, et al. Locoregional and distant recurrences after breast-conserving therapy in patients with triple-negative breast cancer: a meta-analysis. Surg Oncol. 2013;22:247\u201355.","journal-title":"Surg Oncol."},{"key":"5259_CR28","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1016\/j.ejca.2014.04.002","volume":"50","author":"A Purushotham","year":"2014","unstructured":"Purushotham A, Shamil E, Cariati M, Agbaje O, Muhidin A, Gillett C, et al. Age at diagnosis and distant metastasis in breast cancer: a surprising inverse relationship. Eur J Cancer. 2014;50:1697\u2013705.","journal-title":"Eur J Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5259-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-016-5259-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5259-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-016-5259-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T21:03:22Z","timestamp":1655845402000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-016-5259-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["5259"],"URL":"https:\/\/doi.org\/10.1245\/s10434-016-5259-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,11]]},"assertion":[{"value":"22 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2016","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}